GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » Debt-to-Asset

Abbott Laboratories (Pakistan) (KAR:ABOT) Debt-to-Asset : 0.01 (As of Mar. 2024)


View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) Debt-to-Asset?

Abbott Laboratories (Pakistan)'s Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₨109 Mil. Abbott Laboratories (Pakistan)'s Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₨54 Mil. Abbott Laboratories (Pakistan)'s Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was ₨36,109 Mil. Abbott Laboratories (Pakistan)'s debt to asset for the quarter that ended in Mar. 2024 was 0.00.


Abbott Laboratories (Pakistan) Debt-to-Asset Historical Data

The historical data trend for Abbott Laboratories (Pakistan)'s Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories (Pakistan) Debt-to-Asset Chart

Abbott Laboratories (Pakistan) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.03 0.01 0.01 -

Abbott Laboratories (Pakistan) Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 - - 0.01

Competitive Comparison of Abbott Laboratories (Pakistan)'s Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott Laboratories (Pakistan)'s Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories (Pakistan)'s Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott Laboratories (Pakistan)'s Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories (Pakistan)'s Debt-to-Asset falls into.



Abbott Laboratories (Pakistan) Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Abbott Laboratories (Pakistan)'s Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(105.99 + 52.228) / 36693.445
=0.00

Abbott Laboratories (Pakistan)'s Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(108.984 + 54.268) / 36108.882
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott Laboratories (Pakistan)  (KAR:ABOT) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Abbott Laboratories (Pakistan) Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Traded in Other Exchanges
N/A
Address
Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120
Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.

Abbott Laboratories (Pakistan) (KAR:ABOT) Headlines

No Headlines